People / Staff

Michael Mandel

Dr. Michael Mandel is chief economic strategist at the Progressive Policy Institute in Washington, where he supervises PPI’s research and policy work across a wide range of topics, including the data-driven economy, the impact of regulation on innovation, and policies to improve production, investment and job growth in the United States and globally. Mandel was co-principal investigator for a Sloan Foundation grant on “Measuring the Impact of Globalization.” Mandel has testified before Congress on impact of regulation on innovation.

Mandel also holds an appointment as senior fellow at Wharton’s Mack Institute for Innovation Management at the University of Pennsylvania, and serves as president and founder of South Mountain Economics LLC, which provides expertise on emerging occupations and emerging industries.  South Mountain Economics is best known for its research reports on the App Economy, which have been cited in a recent White House report, and publications such as the New York Times, Bloomberg, Boston Globe, the Financial Times, the Atlantic, Time, and Forbes.

Mandel received a Ph.D. in economics from Harvard University and formerly served as chief economist at BusinessWeek, where he directed the magazine’s coverage of the domestic and global economies. While at BusinessWeek, Michael was named one of the top 100 business journalists of the 20th century for his writings on innovation and growth. He received multiple awards for his work, including the Gerald Loeb Award for Business and Financial Journalism.  He is the author of four books including Rational Exuberance: Silencing the Enemies of Growth and Why the Future Is Better Than You Think. He is currently revising the third edition of his introductory economics textbook, Economics:The Basics.

Writings

Blog

By / 4.2.2020

In our previous blog post, we wrote about the importance of keeping the food/essentials supply chains open. With hundreds of millions of Americans stuck at home, having a dependable source of food is essential to avoid panic and to stay the course on social distancing. That’s not optional. We equally stressed the importance of the […]

Blog

By / 3.31.2020

This very unique crisis is creating very unique problems. One is how to get food and other essentials from warehouses all over the country into stores and delivered to people’s homes. This is not optional. The supply chain cannot shut down. Americans are confined to their homes, watching the rising tide of deaths. It’s an […]

Blog

By / 3.27.2020

Get ready for the biggest economic and financial roller coaster of all time.  Policymakers in the United States and around the world are opening up the monetary spigots full bore and limbering up spending packages on an unimaginable scale. This comes after more than a decade of low interest rates. In the United States,  Congress […]

Blog

By / 3.19.2020

The Federal Reserve protects the financial system by being ready to lend money to financial institutions that are stressed in a crisis. It’s already in motion, setting up “facilities” to protect money market funds and other investments. But in this unprecedented emergency, we need a government agency that can provide the same financial lifeline to […]

Blog

America now depends on overseas suppliers for more than half of its medical equipment and supplies, up sharply from a few years ago. That’s based on a PPI analysis of government trade and industry data, What happened? As we go through this terrible pandemic, U.S. healthcare providers are suffering from a surprising shortage of medical […]

Blog

By / 3.17.2020

Is the coronavirus about to force us into the Biotech Century? Here’s a follow-up to my previous post. In response to the coronavirus pandemic, government and private researchers are taking the perhaps unprecedented step of testing the safety of a new coronavirus vaccine in volunteers before testing its safety and efficacy in animals. As one […]

Blog

By / 3.15.2020

Can we expect the biopharma folks to quickly find a good treatment for COVID-19? Is it time to bust up regulatory barriers holding back innovation? In March 1997, BusinessWeek magazine, now part of Bloomberg,  ran a cover story entitled “The Biotech Century.” The cover language, in part, said “Thanks to fundamental advances in genetics, biology […]